http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170115020-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b6c6a48cffb28248f876624847fa778 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 |
| filingDate | 2017-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f06ae19f4a8863049a21f1d0b3c03609 |
| publicationDate | 2017-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20170115020-A |
| titleOfInvention | A composition for preventing or protecting neurodegenerative diseases comprising melatonin |
| abstract | The present invention relates to a composition for preventing or treating degenerative neurological diseases containing melatonin as an active ingredient. The melatonin of the present invention improves memory disorders induced by amyloid beta without accumulating cytotoxicity, Since it inhibits the phosphorylation of proteins and inhibits the apoptotic pathway, melatonin can be effectively used as an active ingredient of a pharmaceutical composition for the prevention or treatment of neurodegenerative diseases. |
| priorityDate | 2017-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 184.